Overview of Dr. Arcasoy
Dr. Arcasoy was recruited to Columbia University/NewYork-Presbyterian Hospital as the Medical Director of Lung Transplant Program in 2001 from the University of Pennsylvania, where he was a key member of the Advanced Lung Disease and Lung Transplantation Program. After his recruitment, he completely turned around the Lung Transplant Program to rank amongst the top 3 programs in the country. Under his leadership, the Lung Transplant Program has performed nearly 1,500 lung transplants in the past two decades and more than 100 transplants annually in the past 4 years since 2020. Despite high transplant volumes and very sick pretransplant candidates, the survival of lung transplant recipients has remained significantly above the national average. Currently, 1-year survival of lung transplant recipients at Columbia University is 90%, 5-year survival 65%, and 10-year survival 40%.
Dr. Arcasoy has gained national and international reputation with various leadership roles in many professional organizations and scientific societies. He previously chaired the Thoracic Organ Transplant Committee of the American Society of Transplantation and the Transplant Network Steering Committee of the American College of Chest Physicians. Dr. Arcasoy is a Fellow of the American College of Physicians (FACP), American College of Chest Physicians (FCCP), and American Society of Transplantation (FAST). He is in a leadership position in the Standards&Guidelines Committee of the International Society of Heart and Lung Transplantation. He also serves as a reviewer for many scientific journals. Dr. Arcasoy has been named in America's Top Doctors and Top Doctors: New York Metro area in the past 20 consecutive years. He has been selected in the New York Times Super Doctors list in the past 10 years.
Dr. Arcasoy's main research interests include outcomes of patients with advanced lung disease before and after lung transplantation and clinical trials in new immunosuppressive therapies.
Office
Lung Transplant Program
622 West 168th Street, PH14 East, Suite 104
New York, NY 10032Fax+1 212-342-5382
Education & Training
- Columbia University Vagelos College of Physicians and SurgeonsM.P.H., Public Health in Healthcare Management, 2011 - 2013
- UPMC Medical EducationFellowship, Pulmonary Disease and Critical Care Medicine, 1994 - 1998
- SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1990 - 1994
- Ege Univ- Fac MedClass of 1990
- Tarsus American CollegeBachelors, 1977 - 1984
Certifications & Licensure
- CT State Medical License 1992 - 2025
- NJ State Medical License 2004 - 2025
- NY State Medical License 1993 - 2025
- PA State Medical License 1994 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- New York City Super Doctors New York Times Magazine, 2009-2024
- America's Top Doctors Castle Connolly, 2003-2014, 2016-2020
- New York Magazine: Top Doctors Castle Connolly, 2002-2007, 2010, 2019-2020
- Join now to see all
Clinical Trials
- Intravenous Immunoglobulin (IVIG) in Lung Transplantation Start of enrollment: 2005 Jun 01
- Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2) Start of enrollment: 2019 Mar 29
- Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) Start of enrollment: 2019 Apr 02
Publications & Presentations
PubMed
- The Secondary Pulmonary Hypertension Diagnosis is Not Useful in Lung Allocation.Mark A Sonnick, Kemarut Laothamatas, David Furfaro, Frank D'Ovidio, Philippe Lemaitre
Transplantation Proceedings. 2024-10-01 - Lung Transplantation for Pulmonary AL Amyloidosis.Matthew I Ehrlich, Michael S Hughes, Brian W Labadie, Markus D Siegelin, Frank D'Ovidio
Transplantation Direct. 2024-03-01 - Changing patterns in lung transplant for respiratory failure due to COVID-19 in the U.S.Kemarut Laothamatas, Luke Benvenuto, Frank D'Ovidio, Selim M Arcasoy
The Journal of Heart and Lung Transplantation. 2024-02-01
Journal Articles
- Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosisEur Resp J, 1/1/2013
- Interobserver variability in grading transbronchial lung biopsies after lung transplantationChest, 1/1/2013
- Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantationTransl Res, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Elevated Monocyte Chemotactic Protein-1 (MCP-1) Is Associated With Primary Graft Dysfunction Following Lung TransplantationAm J Respir Crit Care Med, 1/1/2011
- PTX3 Polymorphisms Are Associated with Primary Graft Dysfunction after Lung TransplantationJ Heart Lung Transplant, 1/1/2011
- Elevated PTX3 Concentration Is Associated with Primary Graft Dysfunction after Lung Transplantation in Patients with Idiopathic Pulmonary FibrosisJ Heart Lung Transplant, 1/1/2011
- Join now to see all
Lectures
- International Collaboration in Lung TransplantationIstanbul, Turkey - 1/1/2013
- Lung Transplantation. 2013 UpdateMedica Health Clinic, Istanbul, Turkey - 1/1/2013
- Lung Transplantation in Interstitial Lung Disease and Pulmonary FibrosisColumbia University College of Physicians and Surgeons and NewYork-Presbyterian Hospital, White Plai - 1/1/2012
- Join now to see all
Other
- Lung Transplant in the COPD PatientLung Health Professional Magazine
1/1/2011 - Pancoast's syndrome and superior (pulmonary) sulcus tumorsArcasoy SM, Jett JR, Schild SE
http://www.uptodate.com/contents/pancoasts-syndrome-and-superior-pulmonary-sulcus-tumors
UpToDate, Wolters Kluwer Health - 2012-03-28
Authored Content
- My Spotify Podcast about Advances in Lung TransplantationJune 2024
Press Mentions
- Expert Experience: Achieving Greater Success in Lung Transplantation Through Access & InnovationJune 17th, 2024
- Lung Patients See a New Era of TransplantsSeptember 24th, 2006
- At the Leading Edge of Lung TransplantationApril 17th, 2024
- Join now to see all
Grant Support
- Pathogenesis Of Airway Disease In Cystic FibrosisNational Heart, Lung, And Blood Institute1996–1997
Committees
- Associate Chair, Advanced Lung Failure and Lung Transplant, Standards and Guidelines, ISHLT 2019 - 2024
Professional Memberships
- Fellow
- Fellow
- Member
- American Society of TransplantationFellow
- International Society for Heart and Lung TransplantationMember
- New York State Cardiothoracic Transplant ConsortiumMember
Other Languages
- Turkish
External Links
- My Spotify podcast regarding advances in Lung Transplant https://open.spotify.com/episode/2ok1nVjoUqzzJcqvlwE9FE?si=QK5abO8ZROCJnwhWdOvtXA
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS North Carolina BlueOptions PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Great West PPO
Healthfirst New YorkHIP of New York - Select PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: